Oncopeptides AB Cash Flow Reinvestment Rate
Latest as of June 2024:
0.00x
Oncopeptides AB cash flow reinvestment rate. Oncopeptides AB (ONCO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr8.77 Million. Explore ONCO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr8.77 Million
SEK
Capital Expenditures
Skr0.00
SEK
Oncopeptides AB Cash Flow Reinvestment Rate by Year (None–None)
Oncopeptides AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Oncopeptides AB. For the full cash flow conversion analysis, see ONCO operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow